Mark Christopherson

Mark Christopherson is a seasoned medtech executive with over three decades of experience in innovation and leadership. They served as the Senior Vice President of Research and Development at NxThera, where they contributed to the development of a BPH treatment that received both European and FDA approvals. Following this, they held the role of Senior Vice President at Cardionomic Inc. and became CEO of Cryosa Inc., focusing on treatments for obstructive sleep apnea. Mark is currently the Chief Executive Officer of Lunair Medical and continues to serve on the board of Bone Foam Inc., while previously acting as an Entrepreneur in Residence at Solas BioVentures. They hold degrees in Physics and Electrical Engineering from Bethel University and the University of Minnesota.